Atrinsic (PTIX) to Release Earnings on Tuesday

Atrinsic (NASDAQ:PTIX – Get Free Report) is expected to issue its resultson Tuesday, August 18th. Analysts expect the company to post earnings of ($4.48) per share for the quarter.

Atrinsic Price Performance

PTIX opened at $0.35 on Tuesday. The stock’s 50 day simple moving average is $0.33 and its 200 day simple moving average is $0.48. Atrinsic has a 1 year low of $0.13 and a 1 year high of $6.20. The firm has a market cap of $633,500.00, a price-to-earnings ratio of -0.04 and a beta of 1.07.

Get Atrinsic alerts:

Atrinsic Company Profile

(Get Free Report)

Protagenic Therapeutics, Inc, a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound comprises PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. Protagenic Therapeutics, Inc is headquartered in New York, New York.

See Also

• Five stocks we like better than Atrinsic
• SoundHound AI Sends a Loud Signal After Its Q2 Earnings Beat
• 3 Dividend Champion Utilities for a Market That Can’t Sit Still
• These 3 Most-Upgraded Stocks Have Almost Nothing to Do With AI
• First Solar’s Profit Engine Faces a New Policy Test in Washington

Receive News & Ratings for Atrinsic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atrinsic and related companies with MarketBeat.com's FREE daily email newsletter.